BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kim SH, Lee EC, Lee SD, Park SJ. Ligation and cut as a method for bile duct division in living donor right hepatectomy. Liver Transpl 2017;23:448-56. [DOI: 10.1002/lt.24670] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
Number Citing Articles
1 Safwan M, Nagai S, Collins K, Rizzari M, Yoshida A, Abouljoud M. Impact of abdominal shape on living liver donor outcomes in mini-incision right hepatic lobectomy: Comparison among 3 techniques. Liver Transpl 2018;24:516-27. [DOI: 10.1002/lt.25001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
2 Lee EC, Kim SH, Shim JR, Park SJ. A comparison of desensitization methods: Rituximab with/without plasmapheresis in ABO-incompatible living donor liver transplantation.Hepatobiliary Pancreat Dis Int. 2018;17:119-125. [PMID: 29576278 DOI: 10.1016/j.hbpd.2018.02.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
3 Lee EC, Kim SH, Shim JR, Park SJ. Small-for-size grafts increase recurrence of hepatocellular carcinoma in liver transplantation beyond milan criteria. Liver Transpl. 2018;24:35-43. [PMID: 28885774 DOI: 10.1002/lt.24868] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
4 Kim SH, Lee EC, Shim JR, Park SJ. Right lobe living donors ages 55 years old and older in liver transplantation. Liver Transpl. 2017;23:1305-1311. [PMID: 28734130 DOI: 10.1002/lt.24823] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
5 Kim SH, Park J, Park SJ. Impact of ABO-incompatibility on hepatic artery thrombosis in living donor liver transplantation. Ann Transl Med 2019;7:625. [PMID: 31930026 DOI: 10.21037/atm.2019.11.34] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Kim SH, Lee EC, Na BG, Park SJ. Impact of ABO-incompatibility on hepatocellular carcinoma recurrence after living donor liver transplantation. Eur J Surg Oncol 2019;45:180-6. [PMID: 30243467 DOI: 10.1016/j.ejso.2018.07.066] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
7 Kim SH, Lee EC, Shim JR, Park SJ. A simplified protocol using rituximab and immunoglobulin for ABO-incompatible low-titre living donor liver transplantation. Liver Int. 2018;38:932-939. [PMID: 29053910 DOI: 10.1111/liv.13614] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
8 Lee EC, Kim SH, Park SJ. Safety and Efficacy of Once-Daily Prolonged-Release Tacrolimus in Living Donor Liver Transplantation: An Open-Label, Prospective, Single-Arm, Phase 4 Study. Ann Transplant 2018;23:713-20. [PMID: 30310047 DOI: 10.12659/AOT.910618] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]